Pfizer Inc. (PFE) Beats Q2 Market Expectations with $13.3 Billion in Revenue
Pfizer Inc. reported a strong Q2 performance in 2024, with total revenues reaching $13.3 billion.
BTC$62,650.00-4.92%
ETH$1,684.36-4.94%
USDT$0.9979-0.12%
USDC$0.9998+0.01%
XRP$1.14-5.92%
SOL$68.76-7.01%
TRX$0.3187-0.76%
FIGR_HELOC$1.02-0.09%
HYPE$67.29-11.40%
DOGE$0.0824-5.54%
USDS$0.9996-0.02%
RAIN$0.0145-0.87%
LEO$9.56-1.19%
XLM$0.2417+6.95%
ZEC$445.91-10.41%
BTC$62,650.00-4.92%
ETH$1,684.36-4.94%
USDT$0.9979-0.12%
USDC$0.9998+0.01%
XRP$1.14-5.92%
SOL$68.76-7.01%
TRX$0.3187-0.76%
FIGR_HELOC$1.02-0.09%
HYPE$67.29-11.40%
DOGE$0.0824-5.54%
USDS$0.9996-0.02%
RAIN$0.0145-0.87%
LEO$9.56-1.19%
XLM$0.2417+6.95%
ZEC$445.91-10.41%
Procter & Gamble's Q4 performance showcased a mixed bag, with diluted EPS falling short of expectations at $1.27.
Pfizer Inc. reported a strong Q2 performance in 2024, with total revenues reaching $13.3 billion.
Gartner, Inc. (NYSE: IT) reported robust financial results for the second quarter of 2024, with revenues reaching $1.6 billion.
onsemi's financial results for Q2 2024 showed a mixed performance, with revenue declining year-over-year but maintaining strong gross margins.
Revvity Inc. (NYSE: RVTY) reported its financial performance for the Q2 2024: $692 million in revenue, $1.22 EPS, better than expected.
Colgate-Palmolive Co. (NYSE: CL) has reported a robust performance for Q2 with net sales reaching $5.058 billion.
3M Co. (NYSE: MMM) has reported robust second-quarter results for 2024, with sales reaching $6.3 billion, reflecting a slight decline year-over-year.
Aon plc reported an 18% increase in total revenue for Q2, driven by acquired revenues from NFP and organic growth, despite a decrease in operating margin.
Pool Corporation (POOL) reported a mixed second-quarter performance for 2024, with net sales declining by 5% to $1.8 billion, but maintaining a solid gross margin.
RTX (NYSE: RTX) reported a solid performance for the second quarter of 2024, with reported sales reaching $19.8 billion.
Honeywell's second-quarter performance in 2024 exceeded market expectations, with reported sales of $9.6 billion and earnings per share at $2.49.
For Tesla, a major turning point will have to take place. Otherwise, Chinese and Japanese automakers will win the long game.
Boston Scientific Corporation (NYSE: BSX) has reported robust financial results for the second quarter of 2024.